Company intelligence / Profile preview

Hamamatsu Pharma Research

Hamamatsu City, Shizuoka Prefecture, Japanhpharmausa.com ↗

Ownership: Private
Development stage: Other

Overview

Hamamatsu Pharma Research specializes in preclinical pharmacological efficacy studies using nonhuman primate disease models. It supports early-stage drug discovery by providing translational research services to evaluate the efficacy of novel therapeutics, especially biologics such as monoclonal antibodies. The company has developed original monkey pathology models and offers advanced neuroimaging capabilities for comprehensive evaluation of potential therapeutics.

Therapeutic areas: DermatologyRheumatologyGastroenterologyCardiovascularOphthalmologyNeurology
Modalities: Monoclonal antibodyBiologicSmall molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Hamamatsu Pharma Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hamamatsu Pharma Research.

Explore the full profile